Market Currents
Baxter International (BAX) trades 3.8% lower premarket after it discloses along with partner...
-
Monday, April 16, 2012, 9:22 AM ETBaxter International (BAX) trades 3.8% lower premarket after it discloses along with partner Halozyme Therapeutics that the FDA needs more long-term data on their jointly-developed HyQ product.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
